Government cannot mandate HIV drug coverage, rules Texas judge

U.S. District Judge Reed O'Connor has ruled that the Affordable Care Act's mandate for free coverage of HIV prevention drugs violates the religious freedom of a Christian-owned company, Bloomberg reports.
Braidwood Management Inc. had challenged the provision requiring it to cover Truvada and Descovy, a pair of widely-used pre-exposure prophylactic drugs more commonly known as PrEP. Thousands of Americans — especially gay and bisexual men — take PrEP daily as a preventative measure against HIV.
In their initial complaint, the plaintiffs argued that the ACA mandate "forces religious employers to provide coverage for drugs that facilitate and encourage homosexual behavior, prostitution, sexual promiscuity, and intravenous drug use." O'Connor ultimately sided with the plaintiffs, claiming the defendants did not show a "compelling interest in forcing private, religious corporations to cover PrEP drugs with no cost-sharing and no religious exemptions."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The suit was led by attorney Jonathan Mitchell, the former Republican solicitor general of Texas who is known for his efforts to restrict abortion access in the state. Mitchell argues that the entire preventive services mandate under the ACA is invalid because those who manage the list are too empowered to not have Senate confirmation, Bloomberg writes.
At this time, it's unclear whether O'Connor's ruling will be nationally endorsed; still, it could have a major impact on access to preventative care and important free health services for Americans. "It's a disappointing decision because it has broader implications for harm for folks that are just trying to work and live and access health care," attorney Shelley Skeen told NBC News.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Devika Rao has worked as a staff writer at The Week since 2022, covering science, the environment, climate and business. She previously worked as a policy associate for a nonprofit organization advocating for environmental action from a business perspective.
-
Today's political cartoons - February 22, 2025
Cartoons Saturday's cartoons - bricking it, I can buy myself flowers, and more
By The Week US Published
-
5 exclusive cartoons about Trump and Putin negotiating peace
Cartoons Artists take on alternative timelines, missing participants, and more
By The Week US Published
-
The AI arms race
Talking Point The fixation on AI-powered economic growth risks drowning out concerns around the technology which have yet to be resolved
By The Week UK Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
Oysters could help combat antibiotic resistance
Under the radar The mollusk shows infection-fighting abilities
By Devika Rao, The Week US Published
-
How Trump's executive orders are threatening scientific research
In the spotlight Agencies are purging important health information
By Devika Rao, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
America is leaving WHO. What does that mean for public health?
Today's Big Question Trump orders the withdrawal
By Joel Mathis, The Week US Published